Ambit Biosciences
Latest round
- Series E
Last raised
- May 2013
Total raised
- $159M
Investors
- 16
About Ambit Biosciences
Ambit Biosciences Inc.Founded in 2000 and headquartered in San Diego, US, Ambit Biosciences Inc. focuses on the discovery and development of targeted therapies.Ambit Biosciences Corporation primarily develops targeted therapies for oncology and inflammatory diseases, with quizartinib as its flagship product. This selective FMS-like tyrosine kinase 3 (FLT3) inhibitor is designed to treat acute myeloid leukemia (AML) and is administered orally once daily.66 mn.Ambit Biosciences plans to utilize the funds from its most recent acquisition to support the development and launch of new products and expand into new geographic markets. The focus will be on bolstering its pipeline of oncology therapies. The acquisition by Daiichi Sankyo in September 2014 is expected to facilitate entry into new markets, leveraging Daiichi Sankyo's global reach and resources. The company's strategic initiatives aim to enhance its offerings in oncology and inflammatory diseases, aligning with the trends of growing demand for innovative cancer therapies.
Who invested in Ambit Biosciences
16 investors across 7 rounds
See all investors in Ambit Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
May 1, 2013
Amount
$25M
Investors
Series E
Nov 6, 2012
Amount
$25M
Investors
Series D
Jun 10, 2011
Amount
$22M
Investors
Series D
Nov 14, 2007
Amount
$46M
Investors
Series C
May 12, 2005
Amount
$10M
Investors
Series C
Aug 1, 2004
Amount
$21M
Investors
Series B
Nov 7, 2001
Amount
$10M
Investors
Questions about Ambit Biosciences
Who invested in Ambit Biosciences?
Ambit Biosciences has 16 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ambit Biosciences raised?
Ambit Biosciences has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Ambit Biosciences last raise money?
Ambit Biosciences's most recent round on record is a Series E, in May 2013.
What does Ambit Biosciences do?
Ambit Biosciences is a biotechnology company.
Where is Ambit Biosciences headquartered?
Ambit Biosciences is headquartered in San Diego, US.
Which VCs invest in companies like Ambit Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ambit Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Ambit Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.